TRX.L Stock - Tissue Regenix Group plc
Unlock GoAI Insights for TRX.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $28.65M | $29.49M | $24.48M | $19.75M | $12.83M |
| Gross Profit | $13.62M | $14.04M | $9.14M | $5.63M | $5.13M |
| Gross Margin | 47.5% | 47.6% | 37.3% | 28.5% | 40.0% |
| Operating Income | $349,000 | $-394,000 | $-2,009,999 | $-4,378,000 | $-4,117,000 |
| Net Income | $-713,000 | $-1,713,000 | $-2,695,000 | $-4,792,000 | $-9,709,000 |
| Net Margin | -2.5% | -5.8% | -11.0% | -24.3% | -75.7% |
| EPS | $-0.01 | $-0.02 | $-0.03 | $-0.07 | $-0.28 |
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions. The company provides dCELL technology, a soft tissue decellularisation process that removes DNA and cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductive to stimulate and regenerate native bone growth. In addition, the company provides DermaPure, a decellularised dermal allograft for reinforcement, repair, and replacement of damaged or inadequate integumental tissue and other homologous uses of human integument; and SurgiPure XD, Decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects. Further, it offers OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient's own cells; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Additionally, the company provides DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; CardioPure products; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks for ophthalmology and wound covering; and sports medicine products. The company was incorporated in 2006 and is based in Garforth, the United Kingdom.
Visit WebsiteEarnings History & Surprises
TRX.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | — | $-0.01 | — | — |
Q3 2024 | Sep 10, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 19, 2024 | — | $-0.01 | — | — |
Q3 2023 | Sep 5, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 23, 2023 | — | $-0.01 | — | — |
Q2 2022 | Jun 29, 2022 | — | $-0.02 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-0.02 | — | — |
Q4 2020 | Dec 30, 2020 | — | $-0.10 | — | — |
Q2 2020 | Jun 29, 2020 | — | $-0.16 | — | — |
Q4 2019 | Dec 30, 2019 | — | $-0.25 | — | — |
Q2 2019 | Jun 29, 2019 | — | $-0.35 | — | — |
Q4 2018 | Dec 30, 2018 | — | $-0.32 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.50 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.50 | — | — |
Q1 2016 | Jan 31, 2016 | — | $-0.90 | — | — |
Q3 2015 | Jul 31, 2015 | — | $-0.90 | — | — |
Q1 2015 | Jan 31, 2015 | — | $-0.60 | — | — |
Q3 2014 | Jul 31, 2014 | — | $-0.60 | — | — |
Q1 2014 | Jan 31, 2014 | — | $-0.73 | — | — |
Q3 2013 | Jul 31, 2013 | — | $-0.73 | — | — |
Latest News
Frequently Asked Questions about TRX.L
What is TRX.L's current stock price?
What is the analyst price target for TRX.L?
What sector is Tissue Regenix Group plc in?
What is TRX.L's market cap?
Does TRX.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to TRX.L for comparison